Cymabay Therapeutics (NASDAQ: CBAY)
| Last Price | $6.26 |
| Net Change | $0.02 (0.32%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $6.53 |
| Previous Close Price | $6.24 |
| High Price | $6.55 |
| Low Price | $6.19 |
| Number of Trades | 3,129 |
| Volume | 946,900 |
| Fifty Two Week High | $8.29 (2017-07-27) |
| Fifty Two Week Low | $1.15 (2016-11-09) |
| Average Daily Volume | 722,130 |
| Share Outstanding | 43,760 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $ () |
| 2nd Quarter Earnings | $ () |
| 3nd Quarter Earnings | $ () |
| 4th Quarter Earnings | $ () |
| PE Ratio | $0 |
| EPS Growth | $38.16 |
| Recent Earnings | $ |
| Annual EPS | $-1.05 |
| Last Quarter EPS | $ |
| Market Capitalization | $0.27B |
| Insider Shareholders % | 0.151% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 43,760 |
| Inst. Shareholder % | 25.39% |
| Annual Net Income | $-0.03B |
| TTM Net Profit Margin | $-565.97 |
| 1-Year Return | 178.22% |
| 3-Year Return | 21.55% |
| 5-Year Return | -30.44% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 0% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | 38.16% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 2.11 |